Beta-adrenoceptor antagonists affect amyloid nanostructure; Amyloid hydrogels as drug delivery vehicles

Jenifer Mains, Dimitrios A. Lamprou, Lisa McIntosh, Iain D.H. Oswald, Andrew J. Urquhart*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)
50 Downloads (Pure)

Abstract

Beta-adrenocepetor antagonists (beta-blockers) alter the nanostructure of lysozyme amyloids, resulting in different drug release profiles.

Original languageEnglish
Pages (from-to)5082-5084
JournalChemical Communications
Volume49
Issue number44
Early online date23 Apr 2013
DOIs
Publication statusPublished - 04 Jun 2013
Externally publishedYes

ASJC Scopus subject areas

  • Catalysis
  • Electronic, Optical and Magnetic Materials
  • Ceramics and Composites
  • Chemistry(all)
  • Surfaces, Coatings and Films
  • Metals and Alloys
  • Materials Chemistry

Fingerprint

Dive into the research topics of 'Beta-adrenoceptor antagonists affect amyloid nanostructure; Amyloid hydrogels as drug delivery vehicles'. Together they form a unique fingerprint.

Cite this